Logos Global Management as of Sept. 30, 2021
Portfolio Holdings for Logos Global Management
Logos Global Management holds 57 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alx Oncology Hldgs (ALXO) | 16.8 | $233M | 3.2M | 73.86 | |
| Olema Pharmaceuticals (OLMA) | 7.4 | $103M | 3.7M | 27.56 | |
| Deciphera Pharmaceuticals | 4.5 | $63M | 1.9M | 33.98 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 4.4 | $61M | 1.5M | 41.59 | |
| Dyne Therapeutics (DYN) | 4.2 | $59M | 3.6M | 16.24 | |
| Karuna Therapeutics Ord | 4.1 | $56M | 460k | 122.33 | |
| Forma Therapeutics Hldgs SHS | 3.5 | $49M | 2.1M | 23.19 | |
| Apellis Pharmaceuticals (APLS) | 3.4 | $48M | 1.5M | 32.96 | |
| Ideaya Biosciences (IDYA) | 3.3 | $45M | 1.8M | 25.49 | |
| Compass Pathways Sponsored Ads (CMPS) | 3.0 | $42M | 1.4M | 29.87 | |
| Pmv Pharmaceuticals (PMVP) | 3.0 | $42M | 1.4M | 29.80 | |
| Design Therapeutics (DSGN) | 2.9 | $41M | 2.8M | 14.69 | |
| Dice Therapeutics | 2.7 | $38M | 1.2M | 32.75 | |
| Cytokinetics Com New (CYTK) | 2.6 | $36M | 1.0M | 35.74 | |
| Nkarta (NKTX) | 2.6 | $36M | 1.3M | 27.81 | |
| Kezar Life Sciences (KZR) | 2.6 | $35M | 4.1M | 8.64 | |
| Aligos Therapeutics (ALGS) | 2.2 | $30M | 2.0M | 15.51 | |
| Arena Pharmaceuticals Com New | 2.2 | $30M | 510k | 59.55 | |
| Miragen Therapeutics (VRDN) | 1.8 | $25M | 1.5M | 16.45 | |
| Instil Bio | 1.6 | $23M | 1.3M | 17.88 | |
| Verve Therapeutics (VERV) | 1.5 | $21M | 443k | 47.00 | |
| Landos Biopharma | 1.5 | $21M | 1.4M | 14.60 | |
| Graphite Bio | 1.4 | $20M | 1.2M | 16.39 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.3 | $18M | 1.1M | 16.70 | |
| Tyra Biosciences (TYRA) | 1.3 | $18M | 1.0M | 17.59 | |
| Athira Pharma (ATHA) | 1.3 | $17M | 1.9M | 9.38 | |
| Century Therapeutics (IPSC) | 1.2 | $16M | 639k | 25.16 | |
| Jounce Therapeutics | 1.1 | $15M | 2.0M | 7.43 | |
| Prelude Therapeutics (PRLD) | 0.9 | $13M | 400k | 31.25 | |
| Iovance Biotherapeutics (IOVA) | 0.9 | $12M | 500k | 24.66 | |
| Edgewise Therapeutics (EWTX) | 0.8 | $11M | 682k | 15.77 | |
| Biomea Fusion (BMEA) | 0.6 | $8.4M | 702k | 11.97 | |
| Eledon Pharmaceuticals (ELDN) | 0.6 | $8.3M | 1.3M | 6.18 | |
| Essa Pharma Com New (EPIX) | 0.6 | $8.0M | 1.0M | 8.00 | |
| Altimmune Com New (ALT) | 0.6 | $7.9M | 700k | 11.31 | |
| Cogent Biosciences (COGT) | 0.6 | $7.8M | 925k | 8.41 | |
| Atreca Cl A Com (BCEL) | 0.5 | $7.3M | 1.2M | 6.23 | |
| Talaris Therapeutics | 0.5 | $6.9M | 508k | 13.56 | |
| Rain Therapeutics | 0.5 | $6.6M | 465k | 14.21 | |
| Cullinan Oncology (CGEM) | 0.5 | $6.5M | 289k | 22.57 | |
| Gh Research Ordinary Shares (GHRS) | 0.5 | $6.4M | 324k | 19.85 | |
| Janux Therapeutics (JANX) | 0.3 | $4.8M | 247k | 19.47 | |
| Synlogic | 0.3 | $4.6M | 1.5M | 3.05 | |
| Alpine Immune Sciences | 0.3 | $4.5M | 425k | 10.67 | |
| Shattuck Labs (STTK) | 0.3 | $4.1M | 200k | 20.38 | |
| Ikena Oncology (IKNA) | 0.3 | $3.8M | 300k | 12.62 | |
| Day One Biopharmaceuticals I (DAWN) | 0.2 | $2.8M | 52k | 53.74 | |
| Nuvalent Inc-a (NUVL) | 0.2 | $2.7M | 135k | 20.30 | |
| Somalogic Class A Com | 0.2 | $2.2M | 201k | 11.15 | |
| Kinnate Biopharma | 0.2 | $2.2M | 94k | 23.02 | |
| Omega Therapeutics Common Stock (OMGA) | 0.1 | $1.7M | 88k | 18.85 | |
| Passage Bio (PASG) | 0.1 | $1.2M | 125k | 9.96 | |
| Monte Rosa Therapeutics (GLUE) | 0.1 | $1.1M | 50k | 22.28 | |
| Keros Therapeutics (KROS) | 0.0 | $593k | 15k | 39.53 | |
| Repare Therapeutics Ord (RPTX) | 0.0 | $525k | 20k | 26.25 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $177k | 67k | 2.65 | |
| Mereo Biopharma Group Ads (MREO) | 0.0 | $114k | 47k | 2.43 |
